Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Pediatric Oncology
•
Hematology
•
Sickle Cell
•
Pediatric Hematology
•
Benign Hematology
•
Stem Cell Transplantation
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Related Questions
How do you manage hyperalgesia in patients with sickle cell disease?
What would your next line of treatment be for a patient with Hb SC with history of recurrent VOC and new bone infarct who is already on hydroxyurea and phlebotomy?
Is there any indication for hydroxyurea in patients with sickle cell trait?
Are there any circumstances where you would consider bridging for patients on DOACs?
In a young female with severe osteoporosis due to congenital estrogen deficiency, can estrogen be prescribed if genetic testing for congenital disorders reveals a heterozygous Factor V Leiden mutation?
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
How do you interpret a low VWF activity/antigen ratio, when both activity and antigen levels are above 50%?
What is your target Hgb/Hct for women who are pregnant and have sickle cell disease in whom you are doing scheduled transfusions?
How do you counsel patients with transfusion dependent beta thalassemia about luspatercept?
Is it true that a ferritin above 200 essentially rules out iron deficiency?